| Overview |
| bsm-90287r-50µL |
| Peroxiredoxin 5 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human Peroxiredoxin 5 |
| 140-214/214 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 25824 |
| P30044 |
| PRDX5; Peroxiredoxin 5; AOEB166; ACR1; PLP; Peroxisomal Antioxidant Enzyme; Liver Tissue 2D-Page Spot 71B; Thioredoxin Peroxidase PMP20; Antioxidant Enzyme B166; TPx Type VI; SBBI10; PMP20; PRDX6; PRXV; B166; Thioredoxin-Dependent Peroxiredoxin 5; Peroxiredoxin-5 Mitochondrial; Alu Co-Repressor 1; Peroxiredoxin V; MGC142285; MGC117264; MGC142283; Prx-V; Epididymis Secretory Protein Li 55; Thioredoxin Reductase; Alu Corepressor 1; EC 1.11.1.24; EC 1.11.1.15; HEL-S-55 |
| Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
Powered by Bioz